Private company

Innoveren Scientific, Inc.

American surgical and medical instruments and apparatus company1

In its 2023 annual report the company says: “The Company leases a shared office space in Tampa, FL which it uses as its legal address.”50 It is headquartered in Cincinnati, Ohio.1

Last updated Oct 20, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersCincinnati, Ohio1
  • Incorporated inNV2
  • Business address151 W4Th St, Ste 223, Cincinnati, Oh 452022
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

74.1%Gross margin3
-1126.0%Operating margin3
-2271.3%Net margin3
-71.9%Revenue growth, 20223

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue5¢$117.6K
  • Research and development81¢$2.0M
  • Interest15¢$368.1K

Out of $453.5K in revenue.3 The company lost money this year.

Financial statements

Revenue45673$453.5K in 2022+119% since 2017
0$2.5M$5.0M$7.5M$10.0M2017: $207.3K$207.3K20172018: $7.9M$7.9M2018+3702%2019: $8.3M$8.3M2019+6%2020: $2.2M$2.2M2020−74%2021: $1.6M$1.6M2021−25%2022: $453.5K$453.5K2022−72%
Gross profit45673$335.9K in 2022+655% since 2017
0$2.0M$4.0M$6.0M$8.0M2017: $44.5K$44.5K20172018: $5.5M$5.5M2018+12295%2019: $6.3M$6.3M2019+14%2020: $1.4M$1.4M2020−78%2021: $906.8K$906.8K2021−34%2022: $335.9K$335.9K2022−63%
Operating income845673-$5.1M in 2022−60% since 2016
-$40.0M-$30.0M-$20.0M-$10.0M02016: -$12.9M-$12.9M20162017: -$6.1M-$6.1M2017−53%2018: -$4.2M-$4.2M2018−31%2019: -$30.6M-$30.6M2019+629%2020: -$7.1M-$7.1M2020−77%2021: -$5.3M-$5.3M2021−25%2022: -$5.1M-$5.1M2022−3%
Net income845673-$10.3M in 2022−37% since 2016
-$30.0M-$20.0M-$10.0M02016: -$16.2M-$16.2M20162017: -$6.5M-$6.5M2017−60%2018: -$4.4M-$4.4M2018−32%2019: -$29.8M-$29.8M2019+578%2020: -$6.5M-$6.5M2020−78%2021: -$4.8M-$4.8M2021−26%2022: -$10.3M-$10.3M2022+115%
Fiscal year2016201720182019202020212022
Revenue$207.3K4$7.9M5$8.3M6$2.2M7$1.6M3$453.5K3
Cost of revenue$162.8K4$502.8K4$2.1M6$767.0K7$704.7K3$117.6K3
Gross profit$44.5K4$5.5M5$6.3M6$1.4M7$906.8K3$335.9K3
Research and development$1.1M8$491.1K4$204.7K4$106.2K6$1.2M7$3.3K7$2.0M3
Operating expenses$6.2M3$5.4M3
Operating income-$12.9M8-$6.1M4-$4.2M5-$30.6M6-$7.1M7-$5.3M3-$5.1M3
Interest$455.3K8$395.3K8$184.2K5$299.3K6$1.5M7$176.8K3$368.1K3
Income tax
Net income-$16.2M8-$6.5M4-$4.4M5-$29.8M6-$6.5M7-$4.8M3-$10.3M3
Earnings per share-$32.933-$35.063
Shares (weighted, basic)145.7K shares3293.8K shares3

Compare Innoveren Scientific, Inc. with another company

Corporate structure

Innoveren Scientific, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Innoveren Scientific, Inc.

  • Schuyler Hansen Filed SCHEDULE 13G on Innoveren Scientific, Inc., latest Mar 6, 2025
  • FWHC HOLDINGS, LLC Filed SCHEDULE 13D/A on Innoveren Scientific, Inc., latest Feb 6, 2025 (3 filings since Feb 25, 2022)
  • Frederick J. Lynch Filed SC 13G/A on Innoveren Scientific, Inc., latest Feb 14, 2024 (3 filings since Feb 16, 2022)
  • Innoveren Scientific, Inc. Cincinnati, Ohio

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Innoveren Scientific, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$20.4K3 Dec 31, 2022$38.4K3 Dec 31, 2021−46.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.0K3 Apr 30, 2023$95.0K7 Dec 31, 2021−95.8%

Leadership

Who has led Innoveren Scientific, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jarrett S. Gorlin2015–2017
  2. William E. Horne2019–2020
  3. Robert Smith Greif2021

President

  1. Patrick C. Kullmann2015–2017
  2. Robert Smith Greif2020

Chief financial officer

  1. Charles Duane Farrahar2015
  2. Larry W. Papasan2015
  3. Jeffery Scott Wright2015–2017
  4. Jeremy Daniel2021

Chief operating officer

  1. Patrick C. Kullmann2015–2017
20202025
Board members and other officers (16)

Former names

  • H-CYTE, INC.Apr 29, 2019 to May 22, 20232
  • Medovex Corp.May 28, 2014 to Jun 26, 20192
  • SpineZNov 13, 2013 to May 1, 20142

Timeline

  1. Jan 31, 20258-K Other events35
  2. Aug 15, 20248-K Executive or director change36
  3. Jul 2, 20248-K Executive or director change37
  4. Jun 25, 20248-K Change of auditor38
  5. Jun 11, 20248-K Entered a material agreement; Unregistered sale of shares39
  6. May 22, 20248-K Regulation FD disclosure40
  7. Apr 1, 20248-K Executive or director change41
  8. Mar 6, 20248-K Regulation FD disclosure42
  9. Feb 28, 20248-K Entered a material agreement; Unregistered sale of shares; Executive or director change43
  10. Dec 21, 20238-K Regulation FD disclosure; Other events44
  11. Oct 3, 20238-K Entered a material agreement45
  12. Jul 11, 20238-K Bylaws or fiscal year changed; Other events46
  13. Apr 5, 2021New chief executive Robert Smith Greif becomes CEO12
  14. Apr 29, 2019New chief executive William E. Horne becomes CEO13
  15. Jan 29, 2015New chief executive Jarrett S. Gorlin becomes CEO14

Filings

65 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 27 major events, 6 insider forms, 7 large holders, 16 other. The latest 20:

  1. Mar 6, 2025SCHEDULE 13G EDGAR
  2. Feb 6, 2025SCHEDULE 13D/A EDGAR
  3. Jan 31, 20258-K EDGAR
  4. Aug 15, 2024NT 10-Q EDGAR
  5. Aug 15, 20248-K EDGAR
  6. Jul 2, 20248-K EDGAR
  7. Jun 25, 20248-K EDGAR
  8. Jun 11, 20248-K EDGAR
  9. May 22, 20248-K EDGAR
  10. May 16, 2024NT 10-Q EDGAR
  11. Apr 2, 2024NT 10-K EDGAR
  12. Apr 1, 20248-K EDGAR
  13. Mar 6, 20248-K EDGAR
  14. Feb 28, 20248-K EDGAR
  15. Feb 14, 2024SC 13G/A EDGAR
  16. Feb 6, 2024SC 13D/A EDGAR
  17. Jan 18, 20244 PRIMARY DOCUMENT EDGAR
  18. Jan 18, 20244 PRIMARY DOCUMENT EDGAR
  19. Dec 21, 20238-K EDGAR
  20. Nov 15, 202310-Q EDGAR

The 65 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Innoveren Scientific, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARInnoveren Scientific, Inc.1
  • CIK0001591165
  • Employer ID (EIN)46-33122621
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inNevada1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address151 W4Th St, Ste 223, Cincinnati, OH 452021
  • Phone844-633-68391
  • Shares outstanding712,710 as of Nov 10, 202310
  • On EDGAR sinceNov 13, 20131
  • Filings416 in all: 8-K (110), 4 (81), 10-Q (27), 3 (25), CORRESP (18), UPLOAD (17), 10-Q/A (12), 10-K (9)1
    All 44 form types

    SC 13G/A (9), NT 10-Q (8), SC 13G (8), S-1/A (7), D (6), EFFECT (6), SC 13D/A (6), 4/A (5), 8-K/A (4), DEF 14C (4), NT 10-K (4), PRE 14C (4), S-1 (4), 10-K/A (3), 424B4 (3), DEF 14A (3), DRS/A (3), FWP (3), PRE 14A (3), 25-NSE (2), 3/A (2), 424B2 (2), 424B5 (2), 8-A12B/A (2), DRSLTR (2), S-3 (2), 424B1 (1), 424B3 (1), 8-A12B (1), CERTNAS (1), DRS (1), PRER14C (1), S-3/A (1), SC 13D (1), SCHEDULE 13D/A (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) May 10, 2023
    Quarterly report (10-Q) Nov 15, 2023
    Proxy statement (DEF 14A) Sep 11, 2017
    Latest 8-K (8-K) Jan 31, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
    SEC EDGAROther events
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50